However, our results suggest the potential value of CSPG4-CAR.CIKs treatment in GIST, notably “CSPG4-high” tumors, that calls for drug testing in vivo, and then in clinical trials. The gene discussed is CSPG4; the disease is gastrointestinal stromal tumor.